pan>)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the
Company will report fourth quarter and full year 2011 financial results
following the close of the U.S. financial markets on Monday, February
27, 2012.
The Company will host a conference call at 5:00 p.m. ET on Monday,
February 27, 2012. Interested parties can access the conference call by
way of web cast or telephone. The live web cast will be available at www.salix.com.
A replay of the web cast will be available at the same location. The
telephone numbers to access the live conference call are (877) 756-4253
(U.S. and Canada) or (706) 902-2163 (international.) The telephone
numbers to access the replay of the call are (855) 859-2056 or (800)
585-8367 (U.S. and Canada) or (404) 537-3406 (international). The access
code for the call is 49878802.
Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina,
develops and markets prescription pharmaceutical products for the
prevention and treatment of gastrointestinal diseases. Salixs strategy
is to in-license late-stage or marketed proprietary therapeutic drugs,
complete any required development and regulatory submission of these
products, and market them through the Companys gastroenterology
specialty sales and marketing team.
Salix trades on the NASDAQ Global Select Market under the ticker symbol
SLXP.
For more information, please visit our Website at www.salix.com
or contact the Company at 9198621000. Follow us on Twitter
(@SalixPharma) and Facebook (www.facebook.com/SalixPharma)
Information on our web site is not incorporated in our SEC filings.

Information Source: Business Wire